611 results on '"Schirrmacher, Ralf"'
Search Results
2. Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
3. Silicon–Fluoride Acceptors (SiFA) for 18F-Radiolabeling: From Bench to Bedside
4. Next-generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR-targeting peptide [18F]SiTATE
5. Dosimetry of [18F]TRACK, the first PET tracer for imaging of TrkB/C receptors in humans
6. Good practices for the automated production of 18F-SiFA radiopharmaceuticals
7. Correction to: Next‑generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR‑targeting peptide [18F]SiTATE
8. Type II & III inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update
9. Favorable SSTR subtype selectivity of SiTATE: new momentum for clinical [18F]SiTATE PET
10. Toward in vivo proof of binding of 18F-labeled inhibitor [18F]TRACK to peripheral tropomyosin receptor kinases
11. Highlight selection of radiochemistry and radiopharmacy developments by editorial board
12. Toward Imaging Tropomyosin Receptor Kinase (Trk) with Positron Emission Tomography
13. Molecular imaging of cardiac CXCR4 expression in a mouse model of acute myocardial infarction using a novel 68Ga-mCXCL12 PET tracer
14. Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours
15. PET Imaging in Dementia: Mini-Review and Canadian Perspective for Clinical Use
16. Development and biological evaluation of[18F]FMN3PA & [18F]FMN3PU for leucine-rich repeat kinase 2 (LRRK2) in vivo PET imaging
17. Automated production of [18F]SiTATE on a Scintomics GRP™ platform for PET/CT imaging of neuroendocrine tumors
18. CycloSiFA - Towards the Next Generation of Silicon-Fluoride Acceptor based Positron Emission Tomography (PET) Imaging Probes
19. Design, Synthesis, and Evaluation of an 18F-Labeling Dendrimer Radiotracer for Positron Emission Tomography (PET) Imaging of Heparanase
20. Radiolabeled Microbubbles as a Theranostic Modality in Nuclear Medicine
21. Design and synthesis of monomeric ligands based on published EGFR (epidermal growth factor receptor)-specific peptides for the diagnostic application in malignant transformations
22. Towards decreased Protodeboronation in the Late-Stage Copper-Mediated Radiofluorination of the Positron Emission Tomography Tracer for Tropomyosin Receptor Kinase [18F]TRACK
23. CycloSiFA: The Next Generation of Silicon‐Based Fluoride Acceptors for Positron Emission Tomography (PET)
24. Radiosynthesis of [18F]SiFAlin-TATE for clinical neuroendocrine tumor positron emission tomography
25. Automated synthesis of [18F]Ga-rhPSMA-7/ -7.3: results, quality control and experience from more than 200 routine productions
26. Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update
27. Toward Imaging Tropomyosin Receptor Kinase (Trk) with Positron Emission Tomography
28. Design, synthesis and in vitro evaluation of heterobivalent peptidic radioligands targeting both GRP- and VPAC1-Receptors concomitantly overexpressed on various malignancies – Is the concept feasible?
29. A Nutritional Perspective of Ketogenic Diet in Cancer: A Narrative Review
30. Synthesis, in vitro and in vivo evaluation of 18F-fluoronorimatinib as radiotracer for Imatinib-sensitive gastrointestinal stromal tumors
31. Small Prosthetic Groups in 18F-Radiochemistry: Useful Auxiliaries for the Design of 18F-PET Tracers
32. CycloSiFA: Die nächste Generation von Silicium‐basierten Fluoridakzeptoren für die Positronenemissionstomographie (PET).
33. Radiosynthesis of Stable 198 Au-Nanoparticles by Neutron Activation of α v β 3 -Specific AuNPs for Therapy of Tumor Angiogenesis.
34. Dosimetry of [18F]TRACK, the first PET tracer for imaging of TrkB/C receptors in humans.
35. Good practices for the automated production of 18F-SiFA radiopharmaceuticals.
36. List of contributors
37. Silicon-based 18F-radiopharmaceuticals
38. P-234 - Radiolabeled Microbubbles as a Theranostic Modality in Nuclear Medicine
39. P-118 - Design and synthesis of monomeric ligands based on published EGFR (epidermal growth factor receptor)-specific peptides for the diagnostic application in malignant transformations
40. P-036 - Design, Synthesis, and Evaluation of an 18F-Labeling Dendrimer Radiotracer for Positron Emission Tomography (PET) Imaging of Heparanase
41. P-029 - Towards decreased Protodeboronation in the Late-Stage Copper-Mediated Radiofluorination of the Positron Emission Tomography Tracer for Tropomyosin Receptor Kinase [18F]TRACK
42. P-028 - CycloSiFA - Towards the Next Generation of Silicon-Fluoride Acceptor based Positron Emission Tomography (PET) Imaging Probes
43. Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11
44. Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [18F]SiTATE
45. Synthesis, Radiolabeling, and In Vitro and In Vivo Characterization of Heterobivalent Peptidic Agents for Bispecific EGFR and Integrin αvβ3 Targeting
46. Next-generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR-targeting peptide [18F]SiTATE.
47. [ 18 F]TRACK, a PET tracer for imaging of tropomyosin receptor kinases (Trk): efficient radiosynthesis and preliminary evaluation in the TgF344‐AD rat model of Alzheimer’s disease.
48. Synthesis of a Bifunctional Cross‐Bridged Chelating Agent, Peptide Conjugation, and Comparison of 68 Ga Labeling and Complex Stability Characteristics with Established Chelators
49. Toward Optimized 89Zr-Immuno-PET: Side-by-Side Comparison of [89Zr]Zr-DFO-, [89Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [89Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?
50. Simultaneous PET/MRI: The future gold standard for characterizing motor neuron disease—A clinico-radiological and neuroscientific perspective
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.